|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Neutropenia | |||||
| Fever | |||||
| Gram-Positive Bacterial Infections | |||||
| Neoplasms | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Bacterial Infections | |||||
| Communicable Diseases | |||||
| Infection | |||||
| 3 | More general conditions related to this trial | ||||
| Agranulocytosis | |||||
| Hematologic Diseases | |||||
| Leukocyte Disorders | |||||
| Leukopenia | |||||
| 4 | Interventions listed in this trial | ||||
| Antibiotic | |||||
| Vancomycin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Bacterial Agents | |||||
| Anti-Infective Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Pfizer | |||||